Lumen, maker of a handheld metabolism measurement gadget, introduced Thursday it had scooped up $62 million in Sequence B funding.
The spherical was led by Pitango Enterprise Capital with participation from Hanwha Group, Resolute Ventures, RiverPark Ventures, Unorthodox Ventures, Almeda Capital and Disruptive VC.
The corporate beforehand raised $8.5 million in 2019 in addition to a crowdfunding elevate in 2018.
WHAT THEY DO
The startup affords a handheld, breathalyzer-like gadget outfitted with a CO2 sensor. Customers breathe into the gadget, and it analyzes whether or not the physique is burning fat or carbs for gasoline.
Lumen additionally gives an app that collects that information and gives diet suggestions primarily based on outcomes. It additionally integrates with Apple HealthKit, Google Match and Garmin.
The corporate stated it has partnered with analysis establishments like Purdue College’s Whistler Heart for Carbohydrate Analysis, College of Toronto’s School of Kinesiology and Bodily Schooling and ARU Cambridge over the previous yr.
“Till now, finding out metabolism with the usual tools was difficult for each researchers and individuals. The info assortment was minimal and would require individuals to return to a clinic for every measurement and a practitioner to investigate the outcomes,” Merav Mor, chief scientist and cofounder of Lumen, stated in an announcement. “Now researchers can simply gather a number of information factors from individuals and construct extra complicated analysis protocols that unveil new physiological findings.”
Lumen stated it plans to make use of the capital to increase its attain within the U.S. and worldwide, add new personalised diet and way of life suggestions and help its analysis partnerships.
MARKET SNAPSHOT
There are a variety of different digital well being firms targeted on dietary steerage, weight reduction or metabolic care.
Twin Well being pitches an AI-backed mannequin that goals to offer individualized diet, sleep and exercise tips to assist folks stop and reverse metabolic ailments like Kind 2 diabetes. It introduced a $140 million Sequence C elevate in October final yr.
One other firm targeted on metabolic well being and weight reduction, Calibrate, introduced a $100 million Sequence B final yr.
Linked well being tech firm Withings has additionally been increasing into diet suggestions with the acquisition of personalised health and meal planning app 8fit.
